Hideki Garren, Chief Medical Officer at PROTHENA CORP PUBLIC LTD CO (PRTA), sold 2,878 shares at $58.15 ($169K) on 2023-08-16, disclosed to the SEC on 2023-08-16.
Scheduled sale ($169k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.15 | 878 | $51K | 30.3% |
| 2 | $58.15 | 878 | $51K | 30.3% |
| 3 | $58.93 | 748 | $44K | 26.2% |
| 4 | $59.74 | 374 | $22K | 13.3% |
| Total | $58.56 avg | 2,878 | $169K | 100% |
| Filing → |
| PRTA | SELL | 2023-06-16 | $542K | — | Filing → |
| PRTA | SELL | 2023-06-14 | $607K | — | Filing → |
| PRTA | SELL | 2023-03-17 | $581K | — | Filing → |